Compounds > pyrroles
Page last updated: 2024-08-18

pyrroles and azd4547

pyrroles has been researched along with azd4547 in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Balek, L; Buchtova, M; Dosedelova, H; Gudernova, I; Jelinkova, I; Kozubik, A; Krejci, P; Kunova, M; Pivnicka, J; Roubalova, L; Vesela, I1
Castro, P; Coleman, I; Davies, BR; Feng, S; Ittmann, M; Nelson, PS; Shao, L; Smith, PD1
Bruegger, DE; Hoover, L; Jones, JW; Le, T; New, J; Tawfik, O; Thomas, SM; Usman, S; Yalamanchali, S1
Chen, Y; Feng, D; Jiang, R; Li, G; Liu, S; Peng, R; Wei, L; Zheng, S1

Other Studies

4 other study(ies) available for pyrroles and azd4547

ArticleYear
Multikinase activity of fibroblast growth factor receptor (FGFR) inhibitors SU5402, PD173074, AZD1480, AZD4547 and BGJ398 compromises the use of small chemicals targeting FGFR catalytic activity for therapy of short-stature syndromes.
    Human molecular genetics, 2016, Jan-01, Volume: 25, Issue:1

    Topics: Achondroplasia; Animals; Benzamides; Cartilage; Catalysis; Cells, Cultured; Chick Embryo; Chondrocytes; Humans; Mice; Phenylurea Compounds; Piperazines; Pyrazoles; Pyrimidines; Pyrroles; Receptor Protein-Tyrosine Kinases; Receptors, Fibroblast Growth Factor; Signal Transduction; Syndrome

2016
Combination treatment of prostate cancer with FGF receptor and AKT kinase inhibitors.
    Oncotarget, 2017, Jan-24, Volume: 8, Issue:4

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Extracellular Signal-Regulated MAP Kinases; Humans; Male; Mice, SCID; Phosphorylation; Piperazines; Prostatic Neoplasms; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyrazoles; Pyrimidines; Pyrroles; Receptor, Fibroblast Growth Factor, Type 1; Signal Transduction; STAT3 Transcription Factor; Tumor Burden; Xenograft Model Antitumor Assays

2017
Inhibition of fibroblast growth factor receptor with AZD4547 mitigates juvenile nasopharyngeal angiofibroma.
    International forum of allergy & rhinology, 2017, Volume: 7, Issue:10

    Topics: Angiofibroma; Antineoplastic Agents; Benzamides; Cell Movement; Cell Proliferation; Cells, Cultured; Fibroblasts; Human Umbilical Vein Endothelial Cells; Humans; Indoles; Nasopharyngeal Neoplasms; Piperazines; Pyrazoles; Pyrroles; Receptors, Fibroblast Growth Factor; Receptors, Vascular Endothelial Growth Factor

2017
Resistance to FGFR1-targeted therapy leads to autophagy via TAK1/AMPK activation in gastric cancer.
    Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2020, Volume: 23, Issue:6

    Topics: Adenocarcinoma; AMP-Activated Protein Kinases; Animals; Antineoplastic Agents; Autophagy; Benzamides; Cell Culture Techniques; Cell Line, Tumor; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Female; Humans; MAP Kinase Kinase Kinases; Mice; Mice, Inbred BALB C; Piperazines; Protein Kinase Inhibitors; Pyrazoles; Pyridines; Pyrroles; Receptor, Fibroblast Growth Factor, Type 1; Signal Transduction; Stomach Neoplasms

2020